Bar-Or A - Search Results

1

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

Mehling M, Brinkmann V, Antel J, Bar-Or A, Goebels N, Vedrine C, Kristofic C, Kuhle J, Lindberg RL, Kappos L. Mehling M, et al. Neurology. 2008 Oct 14;71(16):1261-7. doi: 10.1212/01.wnl.0000327609.57688.ea. Neurology. 2008. PMID: 18852441

2

Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes.

Williams K, Bar-Or A, Ulvestad E, Olivier A, Antel JP, Yong VW. Williams K, et al. J Neuropathol Exp Neurol. 1992 Sep;51(5):538-49. doi: 10.1097/00005072-199209000-00009. J Neuropathol Exp Neurol. 1992. PMID: 1517774

3

Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand.

Kim HJ, Antel JP, Duquette P, Alleva DG, Conlon PJ, Bar-Or A. Kim HJ, et al. Clin Immunol. 2002 Aug;104(2):105-14. doi: 10.1006/clim.2002.5258. Clin Immunol. 2002. PMID: 12165271 Clinical Trial.

4

Do myelin-directed antibodies predict multiple sclerosis?

Antel JP, Bar-Or A. Antel JP, et al. N Engl J Med. 2003 Jul 10;349(2):107-9. doi: 10.1056/NEJMp030098. N Engl J Med. 2003. PMID: 12853581 No abstract available.

5

Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients.

Kim HJ, Biernacki K, Prat A, Antel JP, Bar-Or A. Kim HJ, et al. Clin Immunol. 2004 Apr;111(1):38-46. doi: 10.1016/j.clim.2004.01.004. Clin Immunol. 2004. PMID: 15093550

6

Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.

Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, Lapierre Y, Jalili F, Bar-Or A. Kim HJ, et al. J Immunol. 2004 Jun 1;172(11):7144-53. doi: 10.4049/jimmunol.172.11.7144. J Immunol. 2004. PMID: 15153538

7

Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS.

Magnus T, Schreiner B, Korn T, Jack C, Guo H, Antel J, Ifergan I, Chen L, Bischof F, Bar-Or A, Wiendl H. Magnus T, et al. J Neurosci. 2005 Mar 9;25(10):2537-46. doi: 10.1523/JNEUROSCI.4794-04.2005. J Neurosci. 2005. PMID: 15758163 Free PMC article.

8

Microglia and multiple sclerosis.

Jack C, Ruffini F, Bar-Or A, Antel JP. Jack C, et al. J Neurosci Res. 2005 Aug 1;81(3):363-73. doi: 10.1002/jnr.20482. J Neurosci Res. 2005. PMID: 15948188 Review.

9

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.

Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M. Wiendl H, et al. Brain. 2005 Nov;128(Pt 11):2689-704. doi: 10.1093/brain/awh609. Epub 2005 Aug 25. Brain. 2005. PMID: 16123145

10

Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.

Arbour N, Rastikerdar E, McCrea E, Lapierre Y, Dörr J, Bar-Or A, Antel JP. Arbour N, et al. Mult Scler. 2005 Dec;11(6):652-7. doi: 10.1191/1352458505ms1222oa. Mult Scler. 2005. PMID: 16320724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters